Fresenius SE & Co KGaA FRE.DE · EUR

Its shares trade on XETRA under the ticker FRE.DE. It has been listed since 18 December 1986. It is a member of the DAX. In the fiscal year to 31 December 2025, it reported revenue of €22.87bn and net income of €1.26bn. At that date it held total assets of €41.40bn and shareholders' equity of €19.10bn.

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products, and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen. The company operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. The company also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. The company also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Wolfgang KirschIndependent Chairman of the Supervisory Board, since 2021€265,000
• Mr. Michael SenChairman of the Management Board€4.4m
• Dr. Gerd KrickHonorary Chairman of the Supervisory Board€104,000
• Mr. Michael DiekmannIndependent Deputy Chairman of the Supervisory Board, since 2015€180,000
• Ms. Grit GensterIndependent Deputy Chairman of the Supervisory Board, since 2020€310,000
• Ms. Sara HennickenChief Financial Officer, Member of the Management Board€2.1m
• Mr. Pierluigi AntonelliMember of the Management Board, Chief Executive Officer - Fresenius Kabi€2.3m
• Mr. Robert MoellerMember of the Management Board, Chief Executive Officer of Fresenius Helios€2.0m
• Mr. Michael MoserMember of the Management Board, Responsible for Legal, Compliance, Risk Management, ESG, Human Resources, Corporate Audit and Fresenius Vamed€1.9m
• Prof. Dr. D. Michael AlbrechtIndependent Member of the Supervisory Board€180,000
• Mr. Bernd BehlertIndependent Member of the Supervisory Board, Employee Representative€220,000
• Mr. Oscar De PacoIndependent Member of the Supervisory Board€180,000

Overall

83

Environment

78

Social

99

Governance

72

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.